285 related articles for article (PubMed ID: 34193814)
1. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.
Han Q; Zhang Y; Jiao T; Li Q; Ding X; Zhang D; Cai G; Zhu H
Nutr Diabetes; 2021 Jun; 11(1):24. PubMed ID: 34193814
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
An Y; Zhang C; Xu F; Li W; Zeng C; Xie L; Liu Z
Nephrol Dial Transplant; 2020 Jun; 35(6):1009-1016. PubMed ID: 30521014
[TBL] [Abstract][Full Text] [Related]
3. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
[TBL] [Abstract][Full Text] [Related]
4. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
[TBL] [Abstract][Full Text] [Related]
5. Plasma miR-193a-3p can be a potential biomarker for the diagnosis of diabetic nephropathy.
Hong Y; Wang J; Zhang L; Sun W; Xu X; Zhang K
Ann Clin Biochem; 2021 Mar; 58(2):141-148. PubMed ID: 33302703
[TBL] [Abstract][Full Text] [Related]
6. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Ching-Ha KB; Ka-Bik L; Mac-Moune LF; Cheung-Lung CP; Gang W; Kai-Ming C; Kam-Tao LP
Dis Markers; 2012; 33(3):137-44. PubMed ID: 22960330
[TBL] [Abstract][Full Text] [Related]
7. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
Xu J; Hu XF; Huang W; Shen PY; Zhang W; Ren H; Li X; Wang WM; Chen N; Pan XX
Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):924-929. PubMed ID: 29202533
[No Abstract] [Full Text] [Related]
8. Clinicopathological study of nondiabetic renal disease in type 2 diabetic patients: A single center experience from India.
Kanodia KV; Vanikar AV; Nigam L; Patel RD; Suthar KS; Patel H
Saudi J Kidney Dis Transpl; 2017; 28(6):1330-1337. PubMed ID: 29265044
[TBL] [Abstract][Full Text] [Related]
9. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1.
Meng L; Li G; Liu X; Jiang J; Zhu M; Sun Y
Clin Lab; 2018 Jul; 64(7):1177-1182. PubMed ID: 30146830
[TBL] [Abstract][Full Text] [Related]
10. Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy.
Li S; Hao H; Li R; Guo S
Tohoku J Exp Med; 2022 Mar; 256(3):215-223. PubMed ID: 35314529
[TBL] [Abstract][Full Text] [Related]
11. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels.
Duan A; Liu L; Lou Y; Zhang D; Li H; Chen Y; Cui W; Miao L
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307184
[TBL] [Abstract][Full Text] [Related]
13. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
Eissa S; Matboli M; Bekhet MM
Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
[TBL] [Abstract][Full Text] [Related]
14. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy.
van den Brand JA; Hofstra JM; Wetzels JF
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1242-8. PubMed ID: 22595828
[TBL] [Abstract][Full Text] [Related]
16. Potential Value of Urinary Exosome-Derived let-7c-5p in the Diagnosis and Progression of Type II Diabetic Nephropathy.
Li W; Yang S; Qiao R; Zhang J
Clin Lab; 2018 May; 64(5):709-718. PubMed ID: 29739042
[TBL] [Abstract][Full Text] [Related]
17. Urinary miRNA profile for the diagnosis of IgA nephropathy.
Szeto CC; Wang G; Ng JK; Kwan BC; Mac-Moune Lai F; Chow KM; Luk CC; Lai KB; Li PK
BMC Nephrol; 2019 Mar; 20(1):77. PubMed ID: 30832601
[TBL] [Abstract][Full Text] [Related]
18. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
19. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy.
Bermejo S; Soler MJ; Gimeno J; Barrios C; Rodríguez E; Mojal S; Pascual J
Nefrologia; 2016; 36(5):535-544. PubMed ID: 27523263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
